Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayara D'Auria Jacomassi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
FEBS Letters|October 10, 2015
Emerging targets for combination therapy in melanomasRenata de Freitas Saito, Tharcísio Citrângulo Tortelli, Mayara D'Auria Jacomassi, et al.
Radiation Oncology (London, England)|October 23, 2022
The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?Luís Alberto de Pádua Covas Lage, Vinícius Araújo Soares, Thales Dalessandro Meneguin, et al.
Cancers|April 27, 2024
Predictors of Survival, Treatment Modalities, and Clinical Outcomes of Diffuse Large B-Cell Lymphoma in Patients Older Than 70 Years Still an Unmet Medical Need in 2024 Based on Real-World EvidenceLuís Alberto de Pádua Covas Lage, Rita Novello De Vita, Lucas Bassolli de Oliveira Alves, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
FEBS Letters|October 10, 2015
Emerging targets for combination therapy in melanomasRenata de Freitas Saito, Tharcísio Citrângulo Tortelli, Mayara D'Auria Jacomassi, et al.
Radiation Oncology (London, England)|October 23, 2022
The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?Luís Alberto de Pádua Covas Lage, Vinícius Araújo Soares, Thales Dalessandro Meneguin, et al.
Cancers|April 27, 2024
Predictors of Survival, Treatment Modalities, and Clinical Outcomes of Diffuse Large B-Cell Lymphoma in Patients Older Than 70 Years Still an Unmet Medical Need in 2024 Based on Real-World EvidenceLuís Alberto de Pádua Covas Lage, Rita Novello De Vita, Lucas Bassolli de Oliveira Alves, et al.
Pageof 1